 terazosin pharmacokinet effect age incid advers event terazosin new long-act select postsynapt receptor antagonist chemic structur similar prazosin articl pharmacokinet terazosin incid advers event dose-respons studi meta-analysi placebo-control trial total patient peak plasma concentr terazosin hour oral administr long half-lif terazosin hour once-a-day regimen dose plasma level terazosin linear relationship terazosin oral administr pharmacokinet terazosin food age hypertens renal impair advers event administr terazosin minor age incid syncop therapeut dosag terazosin minim terazosin effect pharmacokinet safeti profil favor lipid effect appropri choic antihypertens therapi